Table 1.
Variables | BCAT1 | BCAT2 |
---|---|---|
Other names | BCATc (cytosolic) | BCATm (mitochondrial) |
Tissue distribution | Brain, gonads, activated CD4+ T-cells (25) | Most tissues, excluding liver (43,44); high in exocrine pancreas (44) |
Knockout phenotypes | Activated Bcat1−/− murine T-cells exhibit elevated mTORC1 signaling and glycolytic metabolism (25); bcat-1 null C. elegans have an extended lifespan and healthspan (45) | Bcat2−/− mice have high circulating BCAAs, improved insulin sensitivity and glucose tolerance, and elevated energy expenditure (46); Bcat2−/− mice have lower exercise capacity (47); required in subset of PDAC (24) |
Expression in cancer cells | Over-expressed in: glioblastoma (48); nasopharyngeal carcinoma (39); cancers with elevated MYC? (39) | Over-expressed in: PDAC (KP−/−C model) (16); cancers with active SREBP1 and low AMPK activity? (24) |
BCAT, branched chain amino acid transferase; PDAC, pancreatic ductal adenocarcinoma.